{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Parkinson disease", "alpha-synuclein", "chaperone-mediated autophagy", "lysosomal-associated membrane protein", "macroautophagy", "protein aggregation"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31223479", "DateRevised": {"Year": "2023", "Month": "10", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "06", "Day": "15"}], "Language": ["eng"], "ELocationID": ["18", "10.1186/s40035-019-0159-7"], "Journal": {"ISSN": "2047-9158", "JournalIssue": {"Volume": "8", "PubDate": {"Year": "2019"}}, "Title": "Translational neurodegeneration", "ISOAbbreviation": "Transl Neurodegener"}, "ArticleTitle": "Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy.", "Pagination": {"StartPage": "18", "MedlinePgn": "18"}, "Abstract": {"AbstractText": ["Progressive accumulation of \u03b1-synuclein is a key step in the pathological development of Parkinson's disease. Impaired protein degradation and increased levels of \u03b1-synuclein may trigger a pathological aggregation <i>in vitro</i> and <i>in vivo</i>. The chaperone-mediated autophagy (CMA) pathway is involved in the intracellular degradation processes of \u03b1-synuclein. Dysfunction of the CMA pathway impairs \u03b1-synuclein degradation and causes cytotoxicity.", "In the present study, we investigated the effects on the CMA pathway and \u03b1-synuclein aggregation using bioactive ingredients (Dihydromyricetin (DHM) and Salvianolic acid B (Sal B)) extracted from natural medicinal plants. In both cell-free and cellular models of \u03b1-synuclein aggregation, after administration of DHM and Sal B, we observed significant inhibition of \u03b1-synuclein accumulation and aggregation. Cells were co-transfected with a C-terminal modified \u03b1-synuclein (SynT) and synphilin-1, and then treated with DHM (10 \u03bcM) and Sal B (50 \u03bcM) 16 hours after transfection; levels of \u03b1-synuclein aggregation decreased significantly (68% for DHM and 75% for Sal B). Concomitantly, we detected increased levels of LAMP-1 (a marker of lysosomal homeostasis) and LAMP-2A (a key marker of CMA). Immunofluorescence analyses showed increased colocalization between LAMP-1 and LAMP-2A with \u03b1-synuclein inclusions after treatment with DHM and Sal B. We also found increased levels of LAMP-1 and LAMP-2A both <i>in vitro</i> and <i>in vivo</i>, along with decreased levels of \u03b1-synuclein. Moreover, DHM and Sal B treatments exhibited anti-inflammatory activities, preventing astroglia- and microglia-mediated neuroinflammation in BAC-\u03b1-syn-GFP transgenic mice.", "Our data indicate that DHM and Sal B are effective in modulating \u03b1-synuclein accumulation and aggregate formation and augmenting activation of CMA, holding potential for the treatment of Parkinson's disease."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0004 0368 6968", "grid.412252.2"], "Affiliation": "1Institute of Neuroscience, College of Life and Health Sciences, Northeastern University, Shenyang, Liaoning China."}, {"Identifier": ["0000 0004 1806 3501", "grid.412467.2"], "Affiliation": "6Key Laboratory of Maternal-Fetal Medicine of Liaoning Province and Key Laboratory of Obstetrics and Gynecology of Higher Education of Liaoning Province, Shengjing Hospital of China Medical University, Shenyang, China."}], "LastName": "Wu", "ForeName": "Jia-Zhen", "Initials": "JZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0001 2193 6666", "grid.43519.3a"], "Affiliation": "2Department of Biochemistry, College of Medicine and Health Sciences, United Arab Emirates University, PO Box 17666, Al-Ain, United Arab Emirates."}], "LastName": "Ardah", "ForeName": "Mustafa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0001 0930 2361", "grid.4514.4"], "Affiliation": "3Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, 221 84 Lund, Sweden."}], "LastName": "Haikal", "ForeName": "Caroline", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0001 0930 2361", "grid.4514.4"], "Affiliation": "3Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, 221 84 Lund, Sweden."}], "LastName": "Svanbergsson", "ForeName": "Alexander", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0001 0930 2361", "grid.4514.4"], "Affiliation": "3Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, 221 84 Lund, Sweden."}], "LastName": "Diepenbroek", "ForeName": "Meike", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0001 0930 2361", "grid.4514.4"], "Affiliation": "3Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, 221 84 Lund, Sweden."}, {"Identifier": ["0000 0001 0516 2170", "grid.418818.c"], "Affiliation": "4Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar."}], "LastName": "Vaikath", "ForeName": "Nishant N", "Initials": "NN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0001 0930 2361", "grid.4514.4"], "Affiliation": "3Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, 221 84 Lund, Sweden."}], "LastName": "Li", "ForeName": "Wen", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0000 9678 1884", "grid.412449.e"], "Affiliation": "5Institute of Heath Sciences, China Medical University, 110112 Shenyang, People's Republic of China."}], "LastName": "Wang", "ForeName": "Zhan-You", "Initials": "ZY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0001 0482 5331", "grid.411984.1"], "Affiliation": "7Department of Experimental Neurodegeneration, Center for Nanoscale Microscopy and Molecular Physiology of the Brain, Center for Biostructural Imaging of Neurodegeneration, University Medical Center G\u00f6ttingen, 37073 G\u00f6ttingen, Germany."}, {"Identifier": ["0000 0001 0668 6902", "grid.419522.9"], "Affiliation": "8Max Planck Institute for Experimental Medicine, G\u00f6ttingen, Germany."}], "LastName": "Outeiro", "ForeName": "Tiago F", "Initials": "TF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["0000 0001 0516 2170", "grid.418818.c"], "Affiliation": "4Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar."}], "LastName": "El-Agnaf", "ForeName": "Omar M", "Initials": "OM"}, {"Identifier": ["0000-0002-7770-7376"], "AffiliationInfo": [{"Identifier": ["0000 0004 0368 6968", "grid.412252.2"], "Affiliation": "1Institute of Neuroscience, College of Life and Health Sciences, Northeastern University, Shenyang, Liaoning China."}, {"Identifier": ["0000 0001 0930 2361", "grid.4514.4"], "Affiliation": "3Neural Plasticity and Repair Unit, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, 221 84 Lund, Sweden."}, {"Identifier": ["0000 0000 9678 1884", "grid.412449.e"], "Affiliation": "5Institute of Heath Sciences, China Medical University, 110112 Shenyang, People's Republic of China."}], "LastName": "Li", "ForeName": "Jia-Yi", "Initials": "JY"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Transl Neurodegener", "NlmUniqueID": "101591861", "ISSNLinking": "2047-9158"}, "CoiStatement": "Competing interestsThe authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, et al. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathol. 2006;111(2):101\u2013108. doi: 10.1007/s00401-005-0027-7.", "ArticleIdList": ["10.1007/s00401-005-0027-7", "16482476"]}, {"Citation": "Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839\u2013840. doi: 10.1038/42166.", "ArticleIdList": ["10.1038/42166", "9278044"]}, {"Citation": "Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004;305(5688):1292\u20131295. doi: 10.1126/science.1101738.", "ArticleIdList": ["10.1126/science.1101738", "15333840"]}, {"Citation": "Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. Journal of Biological Chemistry. 2008;283(35):23542\u201323556. doi: 10.1074/jbc.M801992200.", "ArticleIdList": ["10.1074/jbc.M801992200", "PMC2527094", "18566453"]}, {"Citation": "Dice JF. Chaperone-mediated autophagy. Autophagy. 2007;3(4):295\u2013299. doi: 10.4161/auto.4144.", "ArticleIdList": ["10.4161/auto.4144", "17404494"]}, {"Citation": "Yang RX, Gao GD, Mao ZX, Yang Q. Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson's Disease. Parkinsons Dis-Us. 2016.", "ArticleIdList": ["PMC4927950", "27413575"]}, {"Citation": "Auluck PK, Chan HYE, Trojanowski JQ, Lee VMY, Bonini NM. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 2002;295(5556):865\u2013868. doi: 10.1126/science.1067389.", "ArticleIdList": ["10.1126/science.1067389", "11823645"]}, {"Citation": "Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ. Hsp70 reduces alpha-synuclein aggregation and toxicity. Journal of Biological Chemistry. 2004;279(24):25497\u201325502. doi: 10.1074/jbc.M400255200.", "ArticleIdList": ["10.1074/jbc.M400255200", "15044495"]}, {"Citation": "Andrejewski N, Punnonen EL, Guhde G, Tanaka Y, Lullmann-Rauch R, Hartmann D, et al. Normal lysosomal morphology and function in LAMP-1-deficient mice. J Biol Chem. 1999;274(18):12692\u201312701. doi: 10.1074/jbc.274.18.12692.", "ArticleIdList": ["10.1074/jbc.274.18.12692", "10212251"]}, {"Citation": "Eskelinen EL, Schmidt CK, Neu S, Willenborg M, Fuertes G, Salvador N, et al. Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol Biol Cell. 2004;15(7):3132\u20133145. doi: 10.1091/mbc.e04-02-0103.", "ArticleIdList": ["10.1091/mbc.e04-02-0103", "PMC452571", "15121881"]}, {"Citation": "Yang Q, She H, Gearing M, Colla E, Lee M, Shacka JJ, et al. Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy. Science. 2009;323(5910):124\u2013127. doi: 10.1126/science.1166088.", "ArticleIdList": ["10.1126/science.1166088", "PMC2666000", "19119233"]}, {"Citation": "Rout AK, Strub MP, Piszczek G, Tjandra N. Structure of Transmembrane Domain of Lysosome-associated Membrane Protein Type 2a (LAMP-2A) Reveals Key Features for Substrate Specificity in Chaperone-mediated Autophagy. Journal of Biological Chemistry. 2014;289(51):35111\u201335123. doi: 10.1074/jbc.M114.609446.", "ArticleIdList": ["10.1074/jbc.M114.609446", "PMC4271201", "25342746"]}, {"Citation": "Murphy KE, Gysbers AM, Abbott SK, Spiro AS, Furuta A, Cooper A, et al. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease. Movement Disorders. 2015;30(12):1639\u20131647. doi: 10.1002/mds.26141.", "ArticleIdList": ["10.1002/mds.26141", "25594542"]}, {"Citation": "Klucken J, Outeiro TF, Nguyen P, McLean PJ, Hyman BT. Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. Faseb J. 2006;20(12):2050\u20132057. doi: 10.1096/fj.05-5422com.", "ArticleIdList": ["10.1096/fj.05-5422com", "17012257"]}, {"Citation": "Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443(7113):780\u2013786. doi: 10.1038/nature05291.", "ArticleIdList": ["10.1038/nature05291", "17051204"]}, {"Citation": "Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science. 2003;302(5646):819\u2013822. doi: 10.1126/science.1087753.", "ArticleIdList": ["10.1126/science.1087753", "14593166"]}, {"Citation": "Ebrahimi-Fakhari D, Unni VK, Rockenstein E, Masliah E, Hyman BT, McLean PJ. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein. Movement Disorders. 2011;26:S15\u2013SS6.", "ArticleIdList": ["PMC3587176", "21994367"]}, {"Citation": "Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, et al. alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease. Journal of Cell Biology. 2010;190(6):1023\u20131037. doi: 10.1083/jcb.201003122.", "ArticleIdList": ["10.1083/jcb.201003122", "PMC3101586", "20855506"]}, {"Citation": "Baek KH, Park J, Shin I. Autophagy-regulating small molecules and their therapeutic applications. Chem Soc Rev. 2012;41(8):3245\u20133263. doi: 10.1039/c2cs15328a.", "ArticleIdList": ["10.1039/c2cs15328a", "22293658"]}, {"Citation": "Zhuang Pengwei, Zhang Yanjun, Cui Guangzhi, Bian Yuhong, Zhang Mixia, Zhang Jinbao, Liu Yang, Yang Xinpeng, Isaiah Adejobi Oluwaniyi, Lin Yingxue, Jiang Yongbo. Direct Stimulation of Adult Neural Stem/Progenitor Cells In Vitro and Neurogenesis In Vivo by Salvianolic Acid B. PLoS ONE. 2012;7(4):e35636. doi: 10.1371/journal.pone.0035636.", "ArticleIdList": ["10.1371/journal.pone.0035636", "PMC3335811", "22545124"]}, {"Citation": "Ardah MT, Paleologou KE, Lv GH, Menon SA, Abul Khair SB, Lu JH, et al. Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils. Neurobiology of Disease. 2015;74:89\u2013101. doi: 10.1016/j.nbd.2014.11.007.", "ArticleIdList": ["10.1016/j.nbd.2014.11.007", "PMC4882765", "25449909"]}, {"Citation": "Conway KA, Rochet JC, Bieganski RM, Lansbury PT. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science. 2001;294(5545):1346\u20131349. doi: 10.1126/science.1063522.", "ArticleIdList": ["10.1126/science.1063522", "11701929"]}, {"Citation": "Chen T, Liu W, Chao X, Zhang L, Qu Y, Huo J, et al. Salvianolic acid B attenuates brain damage and inflammation after traumatic brain injury in mice. Brain Research Bulletin. 2011;84(2):163\u2013168. doi: 10.1016/j.brainresbull.2010.11.015.", "ArticleIdList": ["10.1016/j.brainresbull.2010.11.015", "21134421"]}, {"Citation": "Durairajan SSK, Yuan Q, Xie L, Chan W-S, Kum W-F, Koo I, et al. Salvianolic acid B inhibits A beta fibril formation and disaggregates preformed fibrils and protects against A beta-induced cytotoxicty. Neurochemistry International. 2008;52(4-5):741\u2013750. doi: 10.1016/j.neuint.2007.09.006.", "ArticleIdList": ["10.1016/j.neuint.2007.09.006", "17964692"]}, {"Citation": "Liu B, Du J, Zeng J, Chen C, Niu S. Characterization and antioxidant activity of dihydromyricetin-lecithin complex. European Food Research and Technology. 2009;230(2):325\u2013331. doi: 10.1007/s00217-009-1175-0.", "ArticleIdList": ["10.1007/s00217-009-1175-0"]}, {"Citation": "Jiang B, Le L, Pan H, Hu K, Xu L, Xiao P. Dihydromyricetin ameliorates the oxidative stress response induced by methylglyoxal via the AMPK/GLUT4 signaling pathway in PC12 cells. Brain Research Bulletin. 2014;109:117\u2013126. doi: 10.1016/j.brainresbull.2014.10.010.", "ArticleIdList": ["10.1016/j.brainresbull.2014.10.010", "25451453"]}, {"Citation": "Hou X, Tong Q, Wang W, Xiong W, Shi C, Fang J. Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways. Life Sciences. 2015;130:38\u201346. doi: 10.1016/j.lfs.2015.03.007.", "ArticleIdList": ["10.1016/j.lfs.2015.03.007", "25818185"]}, {"Citation": "Wu Shixing, Liu Bin, Zhang Qingyu, Liu Jie, Zhou Wei, Wang Chang, Li Mingyi, Bao Shiting, Zhu Runzhi. Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells. PLoS ONE. 2013;8(11):e76886. doi: 10.1371/journal.pone.0076886.", "ArticleIdList": ["10.1371/journal.pone.0076886", "PMC3817187", "24223706"]}, {"Citation": "Shi LY, Zhang T, Liang XY, Hu Q, Huang J, Zhou Y, et al. Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway. Molecular and Cellular Endocrinology. 2015;409(C):92\u2013102. doi: 10.1016/j.mce.2015.03.009.", "ArticleIdList": ["10.1016/j.mce.2015.03.009", "25797177"]}, {"Citation": "Shi LY, Zhang T, Zhou Y, Zeng XL, Ran L, Zhang QY, et al. Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1 alpha-Sirt3 signaling pathway. Endocrine. 2015;50(2):378\u2013389. doi: 10.1007/s12020-015-0599-5.", "ArticleIdList": ["10.1007/s12020-015-0599-5", "25896550"]}, {"Citation": "Xia J, Guo S, Fang T, Feng D, Zhang X, Zhang Q, et al. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways. Food and Chemical Toxicology. 2014;66:7\u201313. doi: 10.1016/j.fct.2014.01.014.", "ArticleIdList": ["10.1016/j.fct.2014.01.014", "24444546"]}, {"Citation": "Du GH, Qiu Y, Zhang JT. Salvianolic acid B protects the memory functions against transient cerebral ischemia in mice. Journal of Asian Natural Products Research. 2000;2(2):145\u2013152. doi: 10.1080/10286020008039903.", "ArticleIdList": ["10.1080/10286020008039903", "11252679"]}, {"Citation": "Hao YB, Xie TP, Korotcov A, Zhou YF, Pang XW, Shan L, et al. Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. Int J Cancer. 2009;124(9):2200\u20132209. doi: 10.1002/ijc.24160.", "ArticleIdList": ["10.1002/ijc.24160", "PMC2849633", "19123475"]}, {"Citation": "Hansen C, Bjorklund T, Petit GH, Lundblad M, Murmu RP, Brundin P, et al. A novel alpha-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of alpha-synuclein-GFP. Neurobiology of Disease. 2013;56:145\u2013156. doi: 10.1016/j.nbd.2013.04.017.", "ArticleIdList": ["10.1016/j.nbd.2013.04.017", "23643841"]}, {"Citation": "Poehler A-M, Xiang W, Spitzer P, May VEL, Meixner H, Rockenstein E, et al. Autophagy modulates SNCA/alpha-synuclein release, thereby generating a hostile microenvironment. Autophagy. 2014;10(12):2171\u20132192. doi: 10.4161/auto.36436.", "ArticleIdList": ["10.4161/auto.36436", "PMC4502760", "25484190"]}, {"Citation": "L\u00e1zaro Diana F., Rodrigues Eva F., Langohr Ramona, Shahpasandzadeh Hedieh, Ribeiro Thales, Guerreiro Patr\u00edcia, Gerhardt Ellen, Kr\u00f6hnert Katharina, Klucken Jochen, Pereira Marcos D., Popova Blagovesta, Kruse Niels, Mollenhauer Brit, Rizzoli Silvio O., Braus Gerhard H., Danzer Karin M., Outeiro Tiago F. Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation. PLoS Genetics. 2014;10(11):e1004741. doi: 10.1371/journal.pgen.1004741.", "ArticleIdList": ["10.1371/journal.pgen.1004741", "PMC4230739", "25393002"]}, {"Citation": "Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC. alpha-synuclein is degraded by both autophagy and the proteasome. Journal of Biological Chemistry. 2003;278(27):25009\u201325013. doi: 10.1074/jbc.M300227200.", "ArticleIdList": ["10.1074/jbc.M300227200", "12719433"]}, {"Citation": "Pivtoraiko VN, Harrington AJ, Mader BJ, Luker AM, Caldwell GA, Caldwell KA, et al. Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction. Journal of Neurochemistry. 2010;114(4):1193\u20131204.", "ArticleIdList": ["PMC2910188", "20534000"]}, {"Citation": "Xilouri M, Vogiatzi T, Vekrellis K, Stefanis L. alpha-synuclein degradation by autophagic pathways - A potential key to Parkinson's disease pathogenesis. Autophagy. 2008;4(7):917\u2013919. doi: 10.4161/auto.6685.", "ArticleIdList": ["10.4161/auto.6685", "18708765"]}, {"Citation": "Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441(7095):880\u2013884. doi: 10.1038/nature04723.", "ArticleIdList": ["10.1038/nature04723", "16625205"]}, {"Citation": "Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441(7095):885\u2013889. doi: 10.1038/nature04724.", "ArticleIdList": ["10.1038/nature04724", "16625204"]}, {"Citation": "Lin YH, Liu AH, Wu HL, Westenbroek C, Song QL, Yu HM, et al. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Abeta (25-35)-induced reduction in BPRP in PC12 cells. Biochem Biophys Res Commun. 2006;348(2):593\u2013599. doi: 10.1016/j.bbrc.2006.07.110.", "ArticleIdList": ["10.1016/j.bbrc.2006.07.110", "16890202"]}, {"Citation": "Caruana M, Hogen T, Levin J, Hillmer A, Giese A, Vassallo N. Inhibition and disaggregation of alpha-synuclein oligomers by natural polyphenolic compounds. Febs Lett. 2011;585(8):1113\u20131120. doi: 10.1016/j.febslet.2011.03.046.", "ArticleIdList": ["10.1016/j.febslet.2011.03.046", "21443877"]}, {"Citation": "Ono K, Yamada M. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. Journal of Neurochemistry. 2006;97(1):105\u2013115. doi: 10.1111/j.1471-4159.2006.03707.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.03707.x", "16524383"]}, {"Citation": "Rao JN, Dua V, Ulmer TS. Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules. Biochemistry-Us. 2008;47(16):4651\u20134656. doi: 10.1021/bi8002378.", "ArticleIdList": ["10.1021/bi8002378", "18366183"]}, {"Citation": "Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Bio. 2009;10(9):623\u2013635. doi: 10.1038/nrm2745.", "ArticleIdList": ["10.1038/nrm2745", "19672277"]}, {"Citation": "Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. Journal of Clinical Investigation. 2008;118(2):777\u2013788.", "ArticleIdList": ["PMC2157565", "18172548"]}, {"Citation": "Cai ZL, Shi JJ, Yang YP, Cao BY, Wang F, Huang JZ, et al. MPP+ impairs autophagic clearance of alpha-synuclein by impairing the activity of dynein. Neuroreport. 2009;20(6):569\u2013573. doi: 10.1097/WNR.0b013e32832986c4.", "ArticleIdList": ["10.1097/WNR.0b013e32832986c4", "19287320"]}, {"Citation": "Malkus KA, Ischiropoulos H. Regional deficiencies in chaperone-mediated autophagy underlie alpha-synuclein aggregation and neurodegeneration. Neurobiology of Disease. 2012;46(3):732\u2013744. doi: 10.1016/j.nbd.2012.03.017.", "ArticleIdList": ["10.1016/j.nbd.2012.03.017", "PMC3352979", "22426402"]}, {"Citation": "Cuervo AM, Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Research. 2014;24(1):92\u2013104. doi: 10.1038/cr.2013.153.", "ArticleIdList": ["10.1038/cr.2013.153", "PMC3879702", "24281265"]}, {"Citation": "Xilouri Maria, Vogiatzi Tereza, Vekrellis Kostas, Park David, Stefanis Leonidas. Abberant \u03b1-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy. PLoS ONE. 2009;4(5):e5515. doi: 10.1371/journal.pone.0005515.", "ArticleIdList": ["10.1371/journal.pone.0005515", "PMC2677735", "19436756"]}, {"Citation": "Crabtree D, Boyer-Guittaut M, Ouyang X, Fineberg N, Zhang J. Dopamine and its metabolites in cathepsin D heterozygous mice before and after MPTP administration. Neuroscience Letters. 2013;538:3\u20138. doi: 10.1016/j.neulet.2013.01.035.", "ArticleIdList": ["10.1016/j.neulet.2013.01.035", "PMC3645893", "23391753"]}, {"Citation": "Kawamata H, McLean PJ, Sharma N, Hyman BT. Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations. Journal of Neurochemistry. 2001;77(3):929\u2013934. doi: 10.1046/j.1471-4159.2001.00301.x.", "ArticleIdList": ["10.1046/j.1471-4159.2001.00301.x", "11331421"]}, {"Citation": "Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. Potential therapeutic applications of autophagy. Nat Rev Drug Discov. 2007;6(4):304\u2013312. doi: 10.1038/nrd2272.", "ArticleIdList": ["10.1038/nrd2272", "17396135"]}, {"Citation": "Shao E, Forgac M. Involvement of the nonhomologous region of subunit A of the yeast V-ATPase in coupling and in vivo dissociation. Journal of Biological Chemistry. 2004;279(47):48663\u201348670. doi: 10.1074/jbc.M408278200.", "ArticleIdList": ["10.1074/jbc.M408278200", "15355963"]}, {"Citation": "Xu YH, Xu K, Sun Y, Liou B, Quinn B, Li RH, et al. Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice. Human Molecular Genetics. 2014;23(15):3943\u20133957. doi: 10.1093/hmg/ddu105.", "ArticleIdList": ["10.1093/hmg/ddu105", "PMC4082362", "24599400"]}, {"Citation": "Gong L, Di C, Xia X, Wang J, Chen G, Shi J, et al. AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells. Int J Oncol. 2016;49(6):2538\u20132548. doi: 10.3892/ijo.2016.3748.", "ArticleIdList": ["10.3892/ijo.2016.3748", "27779641"]}, {"Citation": "Yan XF, Zhao P, Ma DY, Jiang YL, Luo JJ, Liu L, et al. Salvianolic acid B protects hepatocytes from H2O2 injury by stabilizing the lysosomal membrane. World J Gastroenterol. 2017;23(29):5333\u20135344. doi: 10.3748/wjg.v23.i29.5333.", "ArticleIdList": ["10.3748/wjg.v23.i29.5333", "PMC5550782", "28839433"]}, {"Citation": "Bai LJ, Mei XF, Wang YF, Yuan YJ, Bi YL, Li G, et al. The Role of Netrin-1 in Improving Functional Recovery through Autophagy Stimulation Following Spinal Cord Injury in Rats. Front Cell Neurosci. 2017;11.", "ArticleIdList": ["PMC5701630", "29209172"]}, {"Citation": "Hodson N, McGlory C, Oikawa SY, Jeromson S, Song Z, Ruegg MA, et al. Differential localization and anabolic responsiveness of mTOR complexes in human skeletal muscle in response to feeding and exercise. Am J Physiol Cell Physiol. 2017;313(6):C604\u2013CC11. doi: 10.1152/ajpcell.00176.2017.", "ArticleIdList": ["10.1152/ajpcell.00176.2017", "PMC5814591", "28971834"]}, {"Citation": "Ren Z, Yan P, Zhu L, Yang H, Zhao Y, Kirby BP, et al. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation. Psychopharmacology (Berl). 2017.", "ArticleIdList": ["29058041"]}, {"Citation": "Zhang JQ, Wu XH, Feng Y, Xie XF, Fan YH, Yan S, et al. Salvianolic acid B ameliorates depressive-like behaviors in chronic mild stress-treated mice: involvement of the neuroinflammatory pathway. Acta Pharmacol Sin. 2016;37(9):1141\u20131153. doi: 10.1038/aps.2016.63.", "ArticleIdList": ["10.1038/aps.2016.63", "PMC5022100", "27424655"]}, {"Citation": "Jiang P, Guo Y, Dang R, Yang M, Liao D, Li H, et al. Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome. J Neuroinflammation. 2017;14(1):239. doi: 10.1186/s12974-017-1013-4.", "ArticleIdList": ["10.1186/s12974-017-1013-4", "PMC5719935", "29212498"]}, {"Citation": "Liang J, Lindemeyer AK, Shen Y, Lopez-Valdes HE, Martinez-Coria H, Shao XSM, et al. Dihydromyricetin Ameliorates Behavioral Deficits and Reverses Neuropathology of Transgenic Mouse Models of Alzheimer's Disease. Neurochemical Research. 2014;39(6):1171\u20131181. doi: 10.1007/s11064-014-1304-4.", "ArticleIdList": ["10.1007/s11064-014-1304-4", "24728903"]}, {"Citation": "Grossi C, Guccione C, Isacchi B, Bergonzi MC, Luccarini I, Casamenti F, et al. Development of Blood-Brain Barrier Permeable Nanoparticles as Potential Carriers for Salvianolic Acid B to CNS. Planta Med. 2017;83(5):382\u2013391.", "ArticleIdList": ["27002395"]}, {"Citation": "Ren ZX, Zhao YF, Cao T, Zhen XC. Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity. Acta Pharmacologica Sinica. 2016;37(10):1315\u20131324. doi: 10.1038/aps.2016.42.", "ArticleIdList": ["10.1038/aps.2016.42", "PMC5057232", "27374489"]}, {"Citation": "Zhou Jie, Qu Xiao-Dong, Li Zhi-Yun, Wei-Ji, Liu Qi, Ma Yi-Hui, He Jiao-Jiang. Salvianolic Acid B Attenuates Toxin-Induced Neuronal Damage via Nrf2-Dependent Glial Cells-Mediated Protective Activity in Parkinson\u2019s Disease Models. PLoS ONE. 2014;9(7):e101668. doi: 10.1371/journal.pone.0101668.", "ArticleIdList": ["10.1371/journal.pone.0101668", "PMC4081637", "24991814"]}]}], "History": [{"Year": "2019", "Month": "1", "Day": "29"}, {"Year": "2019", "Month": "5", "Day": "24"}, {"Year": "2019", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "22", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "6", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["31223479", "PMC6570948", "10.1186/s40035-019-0159-7", "159"]}}]}